Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care.
Key Features:
-Overcomes the blood-brain barrier using advanced delivery methods.
-Improves drug penetration & specificity with nano and polymer-based systems.
-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.
-Builds preclinical models & identifies biomarkers to support clinical success.
-Designs regulatory-aligned clinical trial strategies for faster translation.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9798898811761
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798898811761
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798898811761
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features: -Overcomes the blood-brain barrier using advanced delivery methods.-Improves drug penetration & specificity with nano and polymer-based systems.-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.-Builds preclinical models & identifies biomarkers to support clinical success.-Designs regulatory-aligned clinical trial strategies for faster translation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798898811761
Quantité disponible : 1 disponible(s)